These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9715627)
21. [Antiangiogenic therapy]. Toi M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900 [TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166 [TBL] [Abstract][Full Text] [Related]
23. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675 [TBL] [Abstract][Full Text] [Related]
24. Endostatin inhibits murine colon carcinoma sinusoidal-type metastases by preferential targeting of hepatic sinusoidal endothelium. Solaun MS; Mendoza L; De Luca M; Gutierrez V; López MP; Olaso E; Lee Sim BK; Vidal-Vanaclocha F Hepatology; 2002 May; 35(5):1104-16. PubMed ID: 11981760 [TBL] [Abstract][Full Text] [Related]
25. Anticancer activity of endostatin redeemed. Wadman M Nature; 1999 Feb; 397(6720):549. PubMed ID: 10050836 [No Abstract] [Full Text] [Related]
27. Angiostatin induces mitotic cell death of proliferating endothelial cells. Hari D; Beckett MA; Sukhatme VP; Dhanabal M; Nodzenski E; Lu H; Mauceri HJ; Kufe DW; Weichselbaum RR Mol Cell Biol Res Commun; 2000 May; 3(5):277-82. PubMed ID: 10964751 [TBL] [Abstract][Full Text] [Related]
28. NCI statement on animal studies of endostatin and angiostatin. Jpn J Clin Oncol; 1998 Jul; 28(7):460. PubMed ID: 9739791 [No Abstract] [Full Text] [Related]
29. Evidence of efficacy: researchers investigating markers for angiogenesis inhibitors. Brower V J Natl Cancer Inst; 2003 Oct; 95(19):1425-7. PubMed ID: 14519742 [No Abstract] [Full Text] [Related]
30. Problems with media gatekeepers. Nature; 1998 May; 393(6681):97. PubMed ID: 9603503 [No Abstract] [Full Text] [Related]
31. Cancer "breakthrough" is still in the future. Health News; 1998 Jun; 4(7):6. PubMed ID: 9624918 [No Abstract] [Full Text] [Related]
32. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Bergers G; Javaherian K; Lo KM; Folkman J; Hanahan D Science; 1999 Apr; 284(5415):808-12. PubMed ID: 10221914 [TBL] [Abstract][Full Text] [Related]
33. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Blezinger P; Wang J; Gondo M; Quezada A; Mehrens D; French M; Singhal A; Sullivan S; Rolland A; Ralston R; Min W Nat Biotechnol; 1999 Apr; 17(4):343-8. PubMed ID: 10207881 [TBL] [Abstract][Full Text] [Related]
34. Endothelial progenitor cells as putative targets for angiostatin. Ito H; Rovira II; Bloom ML; Takeda K; Ferrans VJ; Quyyumi AA; Finkel T Cancer Res; 1999 Dec; 59(23):5875-7. PubMed ID: 10606226 [TBL] [Abstract][Full Text] [Related]
35. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases]. Dejana E Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094 [No Abstract] [Full Text] [Related]
36. Cancer therapy. Setbacks for endostatin. Marshall E Science; 2002 Mar; 295(5563):2198-9. PubMed ID: 11910086 [No Abstract] [Full Text] [Related]
37. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents. Phillips P JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843 [No Abstract] [Full Text] [Related]
38. Starving tumors of their lifeblood. Ezzell C Sci Am; 1998 Oct; 279(4):33-4. PubMed ID: 9768520 [No Abstract] [Full Text] [Related]
39. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Ramchandran R; Dhanabal M; Volk R; Waterman MJ; Segal M; Lu H; Knebelmann B; Sukhatme VP Biochem Biophys Res Commun; 1999 Feb; 255(3):735-9. PubMed ID: 10049780 [TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. Calvo A; Feldman AL; Libutti SK; Green JE Cancer Res; 2002 Jul; 62(14):3934-8. PubMed ID: 12124322 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]